NCT06791577

Brief Summary

The goal of this clinical trial is to evaluate if CO2 Lift reduces bruising and pain after Liposuction. The study also aims to explore changes in patient satisfaction. The main questions this study seeks to answer are:

  • Does CO2 lift reduce the extent of bruising at 7 days post-surgery?
  • How does CO2 lift impact patient-reported pain and satisfaction? In this study, researchers will compare CO2 lift to a placebo (Vaseline) to see if the intervention has a positive effect. The study procedures include:
  • Baseline data collection of sociodemographic variables. Data collection of surgical variables, adverse events, pain scores, and satisfaction scores.
  • During the liposuction procedure the patient will receive CO2 Lift application to one arm, and/or one glute, and/or one half of the lower abdomen, and placebo (Vaseline) to the contralateral part.
  • Apply CO2 lift and Vaseline immediately after surgery, 12 hours later, and then once a day for 3 to 5 days depending of the risk of the flap/skin.
  • Postoperative follow-up with photos of treated areas at 24 hours, 3 days, and 7 days, with bruising quantified using Image J software.

Trial Health

60
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
50

participants targeted

Target at P25-P50 for phase_4

Timeline
Completed

Started Sep 2023

Typical duration for phase_4

Geographic Reach
3 countries

3 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2023

Completed
1.4 years until next milestone

First Submitted

Initial submission to the registry

January 19, 2025

Completed
5 days until next milestone

First Posted

Study publicly available on registry

January 24, 2025

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 15, 2025

Completed
Last Updated

April 30, 2025

Status Verified

April 1, 2025

Enrollment Period

1.8 years

First QC Date

January 19, 2025

Last Update Submit

April 27, 2025

Conditions

Keywords

CarboxytherapyCO2 LiftBody contouringLiposuctionLiposculptureHigh Definition LiposculpturePatient outcomes

Outcome Measures

Primary Outcomes (1)

  • Ecchymosis of the area - 7 days post procedure

    Reduction of ecchymosis in each area, measured using Photomicrographic analysis with ImageJ Software. The unit of measurement will me in cm\^2 of the affected area (bruised) normalized to the total area of the area (in cm\^2).

    7 days

Secondary Outcomes (4)

  • Ecchymosis of the area - 24 hours post procedure

    24 hours

  • Ecchymosis of the area - 3 days post procedure

    3 days

  • Pain Score

    7 days

  • Patient Satisfaction Scores

    6 months

Study Arms (2)

CO2 Lift group

EXPERIMENTAL

* Application of CO2 lift to one arm, and/or one glute, and/or one half of the lower abdomen. * Apply immediately after surgery and 12 hours later. Then one time per day for 3-5 days for patients with low risk for flap/skin ischemia/suffering.

Drug: Carboxytherapy

Control group

PLACEBO COMPARATOR

\* Application of Vaseline to the contralateral area in which CO2 lift was applied, using the same timing protocol as per CO2 lift

Other: Placebo

Interventions

Application of the intervention (CO2 Lift) in the area according to the protocol schedule

CO2 Lift group
PlaceboOTHER

Application of the placebo (Vaseline) in the area according to the protocol schedule

Control group

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients undergoing body contouring procedures (liposuction or liposculpture), either individually or combined with a maximum of two other major aesthetic procedures involving face, breast, or dermo-lipectomy.
  • healthy patients without underlying comorbidities (classified as ASA≤II)

You may not qualify if:

  • Pregnant patients
  • Known allergy to CO2 Lift or Vaseline
  • History of keloid formation or significant dermatological conditions.
  • Coagulopathy or current use of anticoagulant therapy.
  • Skin disorders related to collagen disease.
  • BMI ≥ 32 kg/m2.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Private Practice

São Paulo, Brazil

RECRUITING

Dhara clinic

Bogotá, DC, Colombia

RECRUITING

Private Practice

Mexico City, Mexico City, Mexico

RECRUITING

Related Publications (3)

  • Oliveira SMD, Rocha LB, da Cunha MTR, Cintra MMM, Pinheiro NM, Mendonca AC. Effects of carboxytherapy on skin laxity. J Cosmet Dermatol. 2020 Nov;19(11):3007-3013. doi: 10.1111/jocd.13337. Epub 2020 Feb 24.

    PMID: 32091181BACKGROUND
  • Delgado-Miguel C, Miguel-Ferrero M. Preliminary results of the use of carboxytherapy in the treatment of pathologic scars: A minimally invasive alternative. J Pediatr Surg. 2023 Apr;58(4):679-683. doi: 10.1016/j.jpedsurg.2022.12.008. Epub 2022 Dec 22.

    PMID: 36641310BACKGROUND
  • Waked K, Kierdaj M, Aslani A. The Use of Carboxytherapy for the Treatment of Deep Partial-Thickness Skin Burns After Circumferential and High-Definition Liposuction: Promising Clinical Results in 5 Consecutive Cases. Aesthetic Surg J Open Forum. 2023;5:ojad096. doi:10.1093/asjof/ojad096

    BACKGROUND

MeSH Terms

Conditions

ContusionsInflammationPain, PostoperativeEcchymosisHematoma

Condition Hierarchy (Ancestors)

Wounds, NonpenetratingWounds and InjuriesPathologic ProcessesPathological Conditions, Signs and SymptomsPostoperative ComplicationsPainNeurologic ManifestationsSigns and SymptomsBlood Coagulation DisordersHematologic DiseasesHemic and Lymphatic DiseasesHemorrhageSkin Manifestations

Central Study Contacts

Alfredo Hoyos, MD

CONTACT

Mauricio Perez, MD

CONTACT

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
PREVENTION
Intervention Model
CROSSOVER
Model Details: Each patient serves as their own control, with one area receiving the intervention (CO2 Lift) and the contralateral area receiving placebo (Vaseline)
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Plastic Surgeon

Study Record Dates

First Submitted

January 19, 2025

First Posted

January 24, 2025

Study Start

September 1, 2023

Primary Completion

June 30, 2025

Study Completion

December 15, 2025

Last Updated

April 30, 2025

Record last verified: 2025-04

Data Sharing

IPD Sharing
Will share

Depending upon reasonable request

Shared Documents
STUDY PROTOCOL, SAP, CSR
Time Frame
Immediately after publication.
Access Criteria
Request to the main author

Locations